The cell isolation market is estimated at US$ 5.1 billion by 2024. The market valuation is expected to be US$ 19.1 billion by 2034, registering an impressive CAGR of 14.1%.
The market is a rapidly growing sector driven by advancements in biomedical research and clinical applications. It involves separating specific cell types from heterogeneous samples, enabling precise analysis and experimentation.
Key factors propelling market growth include rising demand for personalized medicine, increasing prevalence of chronic diseases, and expanding research in areas like cancer and regenerative medicine.
Traditional methods, such as centrifugation and filtration, coexist with innovative technologies like magnetic-activated cell sorting (MACS) and fluorescence-activated cell sorting (FACS).
The market is characterized by competitive dynamics, with key players continuously introducing novel isolation techniques and automation to enhance efficiency.
As the demand for targeted cell isolation solutions escalates, the market is poised for sustained expansion, offering promising opportunities for companies developing and supplying cell isolation technologies.
Key Market Trends and Highlights
Attributes | Key Insights |
---|---|
Market Estimated Size in 2024 | US$ 5.1 billion |
Projected Market Size in 2034 | US$ 19.1 billion |
Value-based CAGR from 2024 to 2034 | 14.1% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The scope for global cell isolation market insights expanded at an 18.9% CAGR between 2019 and 2023. The market is anticipated to develop at a CAGR of 14.1% over the forecast period from 2024 to 2034.
Historical CAGR from 2019 to 2023 | 18.9% |
---|---|
Forecast CAGR from 2024 to 2034 | 14.1% |
Between 2019 and 2023, the global market experienced substantial growth, marked by a CAGR of 18.9%. This period witnessed a surge in demand for advanced cell isolation technologies, driven by increased focus on personalized medicine, rising prevalence of chronic diseases, and continuous advancements in biomedical research.
The market expansion during these years reflected the dynamic nature of the biomedical sector, with researchers and healthcare professionals increasingly relying on precise cell isolation methods to propel their studies and therapeutic developments.
The industry is expected to maintain robust growth, albeit at a slightly moderated pace, with a forecasted CAGR of 14.1% from 2024 to 2034. This projection indicates a positive trajectory, suggesting sustained demand for cell isolation technologies.
Factors contributing to this forecasted growth include an ongoing emphasis on personalized medicine, the persistent rise in chronic diseases globally, and the evolution of innovative isolation techniques.
As the market enters the forecast period, the anticipated expansion underscores the enduring significance of cell isolation in advancing biomedical research and meeting the evolving needs of the healthcare industry.
Attributes | Details |
---|---|
Drivers |
|
The table below highlights CAGRs from the five countries spearheaded by the United States, Japan, China, the United Kingdom, and South Korea. The market in South Korea is dynamic and rapidly advancing, poised for significant growth with a 15.7% CAGR by 2034. Embracing innovation, the country thus, contributes to diverse industries, showcasing a thriving landscape in its economic evolution.
Countries | CAGRs from 2024 to 2034 |
---|---|
The United States | 14.2% |
Japan | 15.4% |
China | 14.4% |
The United Kingdom | 15.5% |
South Korea | 15.7% |
In the United States, the market experiences significant utilization due to the robust biomedical research infrastructure and a thriving healthcare industry.
The demand for cell isolation technologies is driven by extensive research in cancer biology, regenerative medicine, and personalized medicine.
The United States is a global hub for cutting-edge research. Adopting advanced cell isolation methods is pivotal for exploring disease mechanisms, developing targeted therapies, and advancing clinical applications.
The strong emphasis on technological innovation and its leading position in life sciences contribute to the widespread use of cell isolation technologies. The country focuses on precision medicine and advanced healthcare solutions propels the demand for precise cell isolation methods.
The commitment to regenerative medicine and its aging population drive the need for efficient cell isolation techniques in therapeutic applications. This makes it a key market for the continued growth of cell isolation technologies.
The market in China is experiencing substantial growth due to the expanding biomedical research landscape and increasing investments in healthcare infrastructure of the country.
The large population and rising incidences of chronic diseases fuel the demand for advanced cell isolation methods for research and clinical applications. The commitment to scientific innovation and the integration of cell isolation technologies in disease studies contribute to the major utilization within the country.
The prominence of scientific research, particularly in fields like genomics and precision medicine, drives the extensive use of cell isolation technologies.
The well-established healthcare system of the country and focus on translational research contribute to the high demand for advanced cell isolation methods.
The commitment to staying at the forefront of biomedical advancements ensures a sustained need for precise cell isolation techniques in various research and clinical applications.
The dynamic research environment and technological innovation contribute to the significant adoption of cell isolation technologies. The growing interest in personalized medicine, regenerative medicine, and biotechnology fuels the demand for advanced cell isolation methods.
The strategic investments in research and development and a focus on advancing healthcare solutions position cell isolation technologies as crucial tools for advancing scientific understanding and clinical applications within the country.
The table below provides an overview of the cell isolation landscape on the basis of cell type and product type. Human cells are projected to lead the cell type market at a 13.9% CAGR by 2034, while consumables in the product type category are likely to expand at a CAGR of 13.6% by 2034.
The increasing emphasis on personalized medicine and the intricate study of human biology propels the prominence of human cells in the cell isolation landscape. The driving force behind the substantial growth of consumables in the market lies in the integral role these materials play in supporting isolation processes.
Category | CAGR by 2034 |
---|---|
Human Cells | 13.9% |
Consumables | 13.6% |
The cell isolation landscape is categorized based on cell types, with human cells emerging as a prominent segment poised for substantial growth. Projections indicate a CAGR of 13.9% for human cells by 2034.
This signifies a robust and sustained demand for technologies specifically tailored to isolating human cells for various biomedical research and clinical applications.
The increasing focus on personalized medicine and the intricate study of human cell behavior drive the demand for advanced cell isolation techniques, positioning human cells as a pivotal and evolving segment within the broader market.
The market is further delineated based on product types, with consumables significantly shaping the landscape. Projections suggest a noteworthy CAGR of 13.6% for consumables by 2034, highlighting their integral role in cell isolation processes.
Consumables encompass a range of materials essential for cell isolation protocols, including reagents, buffers, and disposable instruments. The consistent demand for these consumables is attributed to the ongoing advancements in isolation technologies and the increasing adoption of automated systems.
As consumables witness sustained growth, they underscore the crucial support infrastructure required for efficient and scalable cell isolation processes across diverse applications in research, diagnostics, and therapeutic development.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The cell isolation market boasts a dynamic and competitive landscape characterized by prominent players striving for innovation and market dominance.
The key players engage in strategic collaborations, mergers, and acquisitions to expand their product portfolios and geographic presence. The competitive arena is further fueled by the influx of new entrants, fostering a climate of innovation and pushing established players to adapt swiftly to emerging trends, ensuring sustained growth in this dynamic market.
Emphasis is placed on automation and user-friendly solutions to enhance efficiency. Strategic partnerships with research institutions and healthcare organizations are integral to market strategies, facilitating the integration of novel technologies into diverse applications.
Some recent developments in the cell isolation domain are as follows:
Attributes | Details |
---|---|
Estimated Market Size in 2024 | US$ 5.1 billion |
Projected Market Valuation in 2034 | US$ 19.1 billion |
CAGR Share from 2024 to 2034 | 14.1% |
Forecast Period | 2024 to 2034 |
Historical Data Available for | 2019 to 2023 |
Market Analysis | Value in US$ billion |
Key Regions Covered |
|
Key Market Segments Covered |
|
Key Countries Profiled |
|
Key Companies Profiled |
|
By 2024, the cell isolation landscape is anticipated to be valued at US$ 5.1 billion.
The cell isolation market is projected to flourish at a CAGR of 14.1% from 2024 to 2034.
By 2034, the cell isolation market will generate US$ 19.1 billion in value terms.
The human cells segment is anticipated to expand at 13.9% CAGR by 2034.
With a CAGR of 13.6%, consumables are expected to dominate the market for cell isolation.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Market Analysis 2019 to 2023 and Forecast, 2024 to 2034
4.1. Historical Market Size Value (US$ Million) Analysis, 2019 to 2023
4.2. Current and Future Market Size Value (US$ Million) Projections, 2024 to 2034
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Cell Type
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) Analysis By Cell Type, 2019 to 2023
5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Cell Type, 2024 to 2034
5.3.1. Human Cells
5.3.2. Animal Cells
5.4. Y-o-Y Growth Trend Analysis By Cell Type, 2019 to 2023
5.5. Absolute $ Opportunity Analysis By Cell Type, 2024 to 2034
6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Product
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) Analysis By Product, 2019 to 2023
6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Product, 2024 to 2034
6.3.1. Consumables
6.3.2. Instruments
6.4. Y-o-Y Growth Trend Analysis By Product, 2019 to 2023
6.5. Absolute $ Opportunity Analysis By Product, 2024 to 2034
7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Technique
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Million) Analysis By Technique, 2019 to 2023
7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Technique, 2024 to 2034
7.3.1. Centrifugation-Based Cell Isolation
7.3.2. Surface Marker-Based Cell Isolation
7.3.3. Filtration-Based Cell Isolation
7.4. Y-o-Y Growth Trend Analysis By Technique, 2019 to 2023
7.5. Absolute $ Opportunity Analysis By Technique, 2024 to 2034
8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By End User
8.1. Introduction / Key Findings
8.2. Historical Market Size Value (US$ Million) Analysis By End User, 2019 to 2023
8.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User, 2024 to 2034
8.3.1. Research Laboratories & Institutes
8.3.2. Hospitals & Diagnostic Laboratories
8.3.3. Cell Banks
8.3.4. Biotechnology & Biopharmaceutical Companies
8.4. Y-o-Y Growth Trend Analysis By End User, 2019 to 2023
8.5. Absolute $ Opportunity Analysis By End User, 2024 to 2034
9. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Application
9.1. Introduction / Key Findings
9.2. Historical Market Size Value (US$ Million) Analysis By Application, 2019 to 2023
9.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Application, 2024 to 2034
9.3.1. Biomolecule Isolation
9.3.2. Cancer Research
9.3.3. Stem Cell Research
9.3.4. Tissue Regeneration
9.3.5. In Vitro Diagnostics
9.3.6. Therapeutics
9.4. Y-o-Y Growth Trend Analysis By Application, 2019 to 2023
9.5. Absolute $ Opportunity Analysis By Application, 2024 to 2034
10. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region
10.1. Introduction
10.2. Historical Market Size Value (US$ Million) Analysis By Region, 2019 to 2023
10.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2024 to 2034
10.3.1. North America
10.3.2. Latin America
10.3.3. Western Europe
10.3.4. Eastern Europe
10.3.5. South Asia and Pacific
10.3.6. East Asia
10.3.7. Middle East and Africa
10.4. Market Attractiveness Analysis By Region
11. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023
11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034
11.2.1. By Country
11.2.1.1. USA
11.2.1.2. Canada
11.2.2. By Cell Type
11.2.3. By Product
11.2.4. By Technique
11.2.5. By End User
11.2.6. By Application
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Cell Type
11.3.3. By Product
11.3.4. By Technique
11.3.5. By End User
11.3.6. By Application
11.4. Key Takeaways
12. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023
12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034
12.2.1. By Country
12.2.1.1. Brazil
12.2.1.2. Mexico
12.2.1.3. Rest of Latin America
12.2.2. By Cell Type
12.2.3. By Product
12.2.4. By Technique
12.2.5. By End User
12.2.6. By Application
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Cell Type
12.3.3. By Product
12.3.4. By Technique
12.3.5. By End User
12.3.6. By Application
12.4. Key Takeaways
13. Western Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023
13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034
13.2.1. By Country
13.2.1.1. Germany
13.2.1.2. UK
13.2.1.3. France
13.2.1.4. Spain
13.2.1.5. Italy
13.2.1.6. Rest of Western Europe
13.2.2. By Cell Type
13.2.3. By Product
13.2.4. By Technique
13.2.5. By End User
13.2.6. By Application
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Cell Type
13.3.3. By Product
13.3.4. By Technique
13.3.5. By End User
13.3.6. By Application
13.4. Key Takeaways
14. Eastern Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023
14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034
14.2.1. By Country
14.2.1.1. Poland
14.2.1.2. Russia
14.2.1.3. Czech Republic
14.2.1.4. Romania
14.2.1.5. Rest of Eastern Europe
14.2.2. By Cell Type
14.2.3. By Product
14.2.4. By Technique
14.2.5. By End User
14.2.6. By Application
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Cell Type
14.3.3. By Product
14.3.4. By Technique
14.3.5. By End User
14.3.6. By Application
14.4. Key Takeaways
15. South Asia and Pacific Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023
15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034
15.2.1. By Country
15.2.1.1. India
15.2.1.2. Bangladesh
15.2.1.3. Australia
15.2.1.4. New Zealand
15.2.1.5. Rest of South Asia and Pacific
15.2.2. By Cell Type
15.2.3. By Product
15.2.4. By Technique
15.2.5. By End User
15.2.6. By Application
15.3. Market Attractiveness Analysis
15.3.1. By Country
15.3.2. By Cell Type
15.3.3. By Product
15.3.4. By Technique
15.3.5. By End User
15.3.6. By Application
15.4. Key Takeaways
16. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
16.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023
16.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034
16.2.1. By Country
16.2.1.1. China
16.2.1.2. Japan
16.2.1.3. South Korea
16.2.2. By Cell Type
16.2.3. By Product
16.2.4. By Technique
16.2.5. By End User
16.2.6. By Application
16.3. Market Attractiveness Analysis
16.3.1. By Country
16.3.2. By Cell Type
16.3.3. By Product
16.3.4. By Technique
16.3.5. By End User
16.3.6. By Application
16.4. Key Takeaways
17. Middle East and Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
17.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023
17.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034
17.2.1. By Country
17.2.1.1. GCC Countries
17.2.1.2. South Africa
17.2.1.3. Israel
17.2.1.4. Rest of MEA
17.2.2. By Cell Type
17.2.3. By Product
17.2.4. By Technique
17.2.5. By End User
17.2.6. By Application
17.3. Market Attractiveness Analysis
17.3.1. By Country
17.3.2. By Cell Type
17.3.3. By Product
17.3.4. By Technique
17.3.5. By End User
17.3.6. By Application
17.4. Key Takeaways
18. Key Countries Market Analysis
18.1. USA
18.1.1. Pricing Analysis
18.1.2. Market Share Analysis, 2023
18.1.2.1. By Cell Type
18.1.2.2. By Product
18.1.2.3. By Technique
18.1.2.4. By End User
18.1.2.5. By Application
18.2. Canada
18.2.1. Pricing Analysis
18.2.2. Market Share Analysis, 2023
18.2.2.1. By Cell Type
18.2.2.2. By Product
18.2.2.3. By Technique
18.2.2.4. By End User
18.2.2.5. By Application
18.3. Brazil
18.3.1. Pricing Analysis
18.3.2. Market Share Analysis, 2023
18.3.2.1. By Cell Type
18.3.2.2. By Product
18.3.2.3. By Technique
18.3.2.4. By End User
18.3.2.5. By Application
18.4. Mexico
18.4.1. Pricing Analysis
18.4.2. Market Share Analysis, 2023
18.4.2.1. By Cell Type
18.4.2.2. By Product
18.4.2.3. By Technique
18.4.2.4. By End User
18.4.2.5. By Application
18.5. Germany
18.5.1. Pricing Analysis
18.5.2. Market Share Analysis, 2023
18.5.2.1. By Cell Type
18.5.2.2. By Product
18.5.2.3. By Technique
18.5.2.4. By End User
18.5.2.5. By Application
18.6. UK
18.6.1. Pricing Analysis
18.6.2. Market Share Analysis, 2023
18.6.2.1. By Cell Type
18.6.2.2. By Product
18.6.2.3. By Technique
18.6.2.4. By End User
18.6.2.5. By Application
18.7. France
18.7.1. Pricing Analysis
18.7.2. Market Share Analysis, 2023
18.7.2.1. By Cell Type
18.7.2.2. By Product
18.7.2.3. By Technique
18.7.2.4. By End User
18.7.2.5. By Application
18.8. Spain
18.8.1. Pricing Analysis
18.8.2. Market Share Analysis, 2023
18.8.2.1. By Cell Type
18.8.2.2. By Product
18.8.2.3. By Technique
18.8.2.4. By End User
18.8.2.5. By Application
18.9. Italy
18.9.1. Pricing Analysis
18.9.2. Market Share Analysis, 2023
18.9.2.1. By Cell Type
18.9.2.2. By Product
18.9.2.3. By Technique
18.9.2.4. By End User
18.9.2.5. By Application
18.10. Poland
18.10.1. Pricing Analysis
18.10.2. Market Share Analysis, 2023
18.10.2.1. By Cell Type
18.10.2.2. By Product
18.10.2.3. By Technique
18.10.2.4. By End User
18.10.2.5. By Application
18.11. Russia
18.11.1. Pricing Analysis
18.11.2. Market Share Analysis, 2023
18.11.2.1. By Cell Type
18.11.2.2. By Product
18.11.2.3. By Technique
18.11.2.4. By End User
18.11.2.5. By Application
18.12. Czech Republic
18.12.1. Pricing Analysis
18.12.2. Market Share Analysis, 2023
18.12.2.1. By Cell Type
18.12.2.2. By Product
18.12.2.3. By Technique
18.12.2.4. By End User
18.12.2.5. By Application
18.13. Romania
18.13.1. Pricing Analysis
18.13.2. Market Share Analysis, 2023
18.13.2.1. By Cell Type
18.13.2.2. By Product
18.13.2.3. By Technique
18.13.2.4. By End User
18.13.2.5. By Application
18.14. India
18.14.1. Pricing Analysis
18.14.2. Market Share Analysis, 2023
18.14.2.1. By Cell Type
18.14.2.2. By Product
18.14.2.3. By Technique
18.14.2.4. By End User
18.14.2.5. By Application
18.15. Bangladesh
18.15.1. Pricing Analysis
18.15.2. Market Share Analysis, 2023
18.15.2.1. By Cell Type
18.15.2.2. By Product
18.15.2.3. By Technique
18.15.2.4. By End User
18.15.2.5. By Application
18.16. Australia
18.16.1. Pricing Analysis
18.16.2. Market Share Analysis, 2023
18.16.2.1. By Cell Type
18.16.2.2. By Product
18.16.2.3. By Technique
18.16.2.4. By End User
18.16.2.5. By Application
18.17. New Zealand
18.17.1. Pricing Analysis
18.17.2. Market Share Analysis, 2023
18.17.2.1. By Cell Type
18.17.2.2. By Product
18.17.2.3. By Technique
18.17.2.4. By End User
18.17.2.5. By Application
18.18. China
18.18.1. Pricing Analysis
18.18.2. Market Share Analysis, 2023
18.18.2.1. By Cell Type
18.18.2.2. By Product
18.18.2.3. By Technique
18.18.2.4. By End User
18.18.2.5. By Application
18.19. Japan
18.19.1. Pricing Analysis
18.19.2. Market Share Analysis, 2023
18.19.2.1. By Cell Type
18.19.2.2. By Product
18.19.2.3. By Technique
18.19.2.4. By End User
18.19.2.5. By Application
18.20. South Korea
18.20.1. Pricing Analysis
18.20.2. Market Share Analysis, 2023
18.20.2.1. By Cell Type
18.20.2.2. By Product
18.20.2.3. By Technique
18.20.2.4. By End User
18.20.2.5. By Application
18.21. GCC Countries
18.21.1. Pricing Analysis
18.21.2. Market Share Analysis, 2023
18.21.2.1. By Cell Type
18.21.2.2. By Product
18.21.2.3. By Technique
18.21.2.4. By End User
18.21.2.5. By Application
18.22. South Africa
18.22.1. Pricing Analysis
18.22.2. Market Share Analysis, 2023
18.22.2.1. By Cell Type
18.22.2.2. By Product
18.22.2.3. By Technique
18.22.2.4. By End User
18.22.2.5. By Application
18.23. Israel
18.23.1. Pricing Analysis
18.23.2. Market Share Analysis, 2023
18.23.2.1. By Cell Type
18.23.2.2. By Product
18.23.2.3. By Technique
18.23.2.4. By End User
18.23.2.5. By Application
19. Market Structure Analysis
19.1. Competition Dashboard
19.2. Competition Benchmarking
19.3. Market Share Analysis of Top Players
19.3.1. By Regional
19.3.2. By Cell Type
19.3.3. By Product
19.3.4. By Technique
19.3.5. By End User
19.3.6. By Application
20. Competition Analysis
20.1. Competition Deep Dive
20.1.1. Thermo Fisher Scientific, Inc.
20.1.1.1. Overview
20.1.1.2. Product Portfolio
20.1.1.3. Profitability by Market Segments
20.1.1.4. Sales Footprint
20.1.1.5. Strategy Overview
20.1.1.5.1. Marketing Strategy
20.1.2. BD
20.1.2.1. Overview
20.1.2.2. Product Portfolio
20.1.2.3. Profitability by Market Segments
20.1.2.4. Sales Footprint
20.1.2.5. Strategy Overview
20.1.2.5.1. Marketing Strategy
20.1.3. Danaher
20.1.3.1. Overview
20.1.3.2. Product Portfolio
20.1.3.3. Profitability by Market Segments
20.1.3.4. Sales Footprint
20.1.3.5. Strategy Overview
20.1.3.5.1. Marketing Strategy
20.1.4. Terumo Corp.
20.1.4.1. Overview
20.1.4.2. Product Portfolio
20.1.4.3. Profitability by Market Segments
20.1.4.4. Sales Footprint
20.1.4.5. Strategy Overview
20.1.4.5.1. Marketing Strategy
20.1.5. STEMCELL Technologies Inc.
20.1.5.1. Overview
20.1.5.2. Product Portfolio
20.1.5.3. Profitability by Market Segments
20.1.5.4. Sales Footprint
20.1.5.5. Strategy Overview
20.1.5.5.1. Marketing Strategy
20.1.6. Bio-Rad Laboratories, Inc.
20.1.6.1. Overview
20.1.6.2. Product Portfolio
20.1.6.3. Profitability by Market Segments
20.1.6.4. Sales Footprint
20.1.6.5. Strategy Overview
20.1.6.5.1. Marketing Strategy
20.1.7. Merck KGaA
20.1.7.1. Overview
20.1.7.2. Product Portfolio
20.1.7.3. Profitability by Market Segments
20.1.7.4. Sales Footprint
20.1.7.5. Strategy Overview
20.1.7.5.1. Marketing Strategy
20.1.8. Agilent Technologies, Inc.
20.1.8.1. Overview
20.1.8.2. Product Portfolio
20.1.8.3. Profitability by Market Segments
20.1.8.4. Sales Footprint
20.1.8.5. Strategy Overview
20.1.8.5.1. Marketing Strategy
20.1.9. Corning Inc.
20.1.9.1. Overview
20.1.9.2. Product Portfolio
20.1.9.3. Profitability by Market Segments
20.1.9.4. Sales Footprint
20.1.9.5. Strategy Overview
20.1.9.5.1. Marketing Strategy
20.1.10. Akadeum Life Sciences
20.1.10.1. Overview
20.1.10.2. Product Portfolio
20.1.10.3. Profitability by Market Segments
20.1.10.4. Sales Footprint
20.1.10.5. Strategy Overview
20.1.10.5.1. Marketing Strategy
21. Assumptions & Acronyms Used
22. Research Methodology
Explore Healthcare Insights
View Reports